Bio and Healthcare Companies Struggle to Raise Funds in Cooling Investment Market
Bio and Healthcare Companies in Korea Experience Decreased Funding in First Half of 2022 Unlisted domestic bio and healthcare companies in Korea have faced significant challenges in raising capital in the first half of this year. According to a recent analysis by Hit News, these companies managed to raise a total of 322.4 billion won […]
Bio and Healthcare Companies in Korea Raise 86.6 Billion Won in Funding despite Market Challenges
During June 2023, nine unlisted bio and healthcare companies in Korea successfully completed their financing initiatives, raising a total amount of 86.6 billion won. These companies were able to secure funding through a range of investment cycles, starting from initial investments to late-stage investments, while also considering early returns. In comparison to the same period […]
Orum Therapeutic unveils clinical design of HER2 target ‘GSPT1 degrader’ at ASCO
Orum Therapeutics (CEO Lee Seung-joo) presented HER2-targeted GSPT1 (G1 to S phase transition) for patients with advanced solid tumors expressing HER2 at the American Society of Clinical Oncology (ASCO) held in Chicago, USA from 2nd (local time) to 5th. We will disclose the design of a phase 1 clinical trial of protein 1) decomposer ‘ORM-5029 […]
